Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: Confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia

Bone Marrow Transplantation

Volumn 24, Issue 9, 1999, Pages 995-1003

  Kodera, Y ^a   Morishima, Y ^b   Kato, S ^c   Akiyama, Y ^d   Sao, H ^e   Matsuyama, T ^a   Kawa, K ^f   Sakamaki, H ^g   Nakagawa, S ^h   Hirabayashi, N ⁱ   Dohi, H ^j   Okamoto, S ^k   Hiraoka, A ^l   Gondo, H ^m   Tsuchida, M ^m   O, H ^m   Harada, M ^m   Asano, S ^m   Juji, T ^m   Sasazuki, T ^m   Takaku, F ^m   more..

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c TOKAI UNIVERSITY HOSPITAL   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e Meitetsu Hospital   (Japan)

^f RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^g TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^h HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

ⁱ NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^j ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^k KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l CENTER FOR ADULT DISEASES   (Japan)

^m NONE

more..

Author keywords

Acute GVHD; Bone marrow transplant from unrelated donor (UR BMT); Chronic GVHD; Japan marrow donor program (JMPD); Survival

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; JAPAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; SCHOOL CHILD;

EID: 0032694870     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702027     Document Type: Article

References (44)

1. Thomas ED. Karnofsky memorial lecture: marrow transplantation for malignant disease. J Clin Oncol 1983; 1: 517-531.
2. Champlin RE, Gale RP. The role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: a critical review of syngeneic autologous and allogeneic transplants. Cancer Treat Rep 1984; 68: 145-161.
3. Hirabayashin N, Kodera Y, Matsuyama T et al. Bone marrow transplantation in 614 patients: twenty year experience of Nagoya Bone Marrow Transplantation Group (NBMTG). Transplant Proc 1995; 27: 1380-1382.
4. Storb RI, Thomas ED, Buckner CD et al. Allogeneic marrow grafting for treatment of aplastic anemia. Blood 1974; 43: 157-180.
5. Champlin R. Treatment of aplastic anemia: current role of bone marrow transplantation and immunomodulatory therapy. In: Gale RP, Champlin RE (eds). Progress in Bone Marrow Transplantation. Alan R Liss: New York, 1987, pp 37-52.
6. Kojima S, Matsuyama T, Kodera Y et al. Allogeneic bone marrow transplantation in 25 patients with severe aplastic anemia. Acta Haematol Jpn 1988; 51: 705-714.
7. Parkman R. The application of bone marrow transplantation to the treatment of genetic disease. Science 1986; 232: 1373-1378.
8. Hansen JA, Beatty PG, Anasetti C et al. Treatment of leukemia by marrow transplantation from donors other than HLA genotypically identical siblings. In: Gale RP, Champlin RE (eds). Progress in Bone Marrow Transplantation. Alan R Liss: New York, 1987, pp 667-676.
9. Horibe K, Yoshida J, Oiwa K et al. Bone marrow transplantation from related donors other than HLA identical siblings in Japanese patients with hematological malignancies. Acta Haematol Jpn 1990; 53: 94-102.
10. Horowitz SD, Groshong T, Bach FH, Hong R. Treatment of severe combined immune deficiency with bone marrow from an unrelated, mixed leukocyte culture nonreactive donor. Lancet 1975; 2: 431-433.
11. O'Reilly RJ, Dupont B, Pahwa S et al. Reconstitution in severe combined immune deficiency by transplantation of marrow from an unrelated donor. New Engl J Med 1977; 297: 1311-1318.
12. The Westminster Hospital Bone Marrow Transplant Team. Bone marrow transplant from an unrelated donor for chronic granulomatous disease. Lancet 1977; 1: 210-213.
13. Speck B, Zwaan FE, van Rood JJ, Eernisse JG. Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HLA-identical unrelated donor. Transplantation 1973; 16: 24-28.
14. Lohman H-P, Dietrich M, Goldmann SF et al. Bone marrow transplantation for aplastic anemia from a HLA and MLC-identical unrelated donor. Blut 1975; 31: 347-354.
15. Hansen JA, Clift RA, Thomas ED et al. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. New Engl J Med 1980; 303: 565-567.
16. Hows JM, Yin JL, Marsh J et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322-1328.
17. Gordon-Smith EC, Fairhead SM, Chipping PM et al. Bone marrow transplantation for severe aplastic anemia using histocompatible unrelated volunteer donors. Br Med J 1982; 285: 835-837.
18. Duquesnoy RJ, Zeevi A, Marrari M et al. Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor. Transplantation 1983; 35: 566-571.
19. Hows JM, Yin JL, Marsh J et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322-1328.
20. Howard MR, Hows JM, Gore SM et al. Unrelated donor marrow transplantation between 1977 and 1987 at four centers in the United Kingdom. Transplantation 1990; 49: 547-553.
21. McGlave P, Scott E, Ramsay N et al. Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia. Blood 1987; 71: 877-881.
22. Gingrich RD, Ginder GD, Goeken NE et al. Allogeneic marrow grafting with partially mismatched unrelated marrow donors. Blood 1988; 71: 1375-1381.
23. Bachigalupo A, Hows J, Gordon-Smith EC et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. Bone Marrow Transplant 1988; 3: 531-535.
24. Camitta B, Ash R, Menitove J et al. Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. Blood 1989; 74: 1852-1857.
25. McGrave PB, Beatty P, Ash R, Hows JM. Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases. Blood 1990; 75: 1728-1732.
26. Mackinnon S, Hows JM, Goldmann JM et al. Bone marrow transplantation for chronic myelold leukemia: the use of histocompatible unrelated volunteer donors. Exp Hematol 1990; 18: 421-425.
27. Gajewski JL, Ho WG, Feig SA et al. Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure. Transplantation 1990; 50: 244-249.
28. Ash RC, Casper JT, Chitamber CR et al. Successful allogeneic transplantation of T cell-depleted bone marrow from closely HLA-matched unrelated donors. New Engl J Med 1990; 322: 485-494.
29. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.
30. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 592-602.
31. Stroncheck DF, Holland PV, Bartch G et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood 1993; 81: 1940-1946.
32. Kodera Y, Mortshima Y, Hirabayashi N et al. Analysis of 55 transplantations from unrelated volunteer donors facilitated by Tokai Marrow Donor Bank. Int Med 1996; 35: 78-83.
33. Morishima Y, Kodera Y, Hirabayashi N et al. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese. Bone Marrow Transplant 1995; 15: 235-239.
34. McCullough J, Rogers G, Dahl R et al. Development and operation of a program to obtain volunteer bone marrow donors unrelated to the patient. Transplantation 1986; 25: 315-323.
35. McElligott MC, Menitove JE, Aster RH. Recruitment of unrelated persons as bone marrow donors: a preliminary experience. Transfusion 1986; 26: 309-314.
36. Kodera Y. Current status of marrow donor programs in Japan. Asian Med J 1996; 39: 541-550.
37. Hopkins KA. Basic microlymphocytotoxicity test. In: Zachary AA, Teresi GA (eds). Laboratory Manual, 2nd edn. American Society for Histocompatibility and Immunogenetics, Lenexa, 1990, pp 195-201.
38. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
39. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference of acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
40. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
41. Morishima Y, Morishita Y, Tanimoto M et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings: possible role of genetic homogeneity. Blood 1989; 74: 2252-2256.
42. The Japanese Society of Pediatric Hematology Bone Marrow Transplantation Committee. National Registry of Bone Marrow Transplantation in Children - 1994. Jpn J Ped Hematol 1994; 8: 492-504.
43. Longmore G, Guinann EC, Weinstein HJ et al. Bone marrow transplantation for myelodysplasia and secondary acute nonlymphocytic leukemia. J Clin Oncol 1990; 8: 1707-1714.
44. Sasazuki T, Juji T, Morishima Y et al. Importance of HLA-class I alle matching for clinical outcome after unrelated donor hematopoietic stem cell transplantation. New Engl J Med 1998; 339: 1177-1185.